1.Date of occurrence of the event:2017/10/13
2.Company name:China Chemical & Pharmaceutical Co., Ltd. 
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):N/A
4.Reciprocal shareholding ratios:N/A 
5.Name of the reporting media:Chinatimes 
6.Content of the report:Tsh Biopharm Co., Ltd. (8432) maintenance main force product to Hypertension Amtrel Tab year 2.5 hundred million Yuan markets, to CCPC proposed the violation 
   exclusive law and violates the fair exchange law lawsuit ......correlation report. 
7.Cause of occurrence:12th day of October,2017, Tsh Biopharm Co., Ltd. (8432) in the media exposition, already to this company proposed the exclusive law and the fair exchange law lawsuit, 
   this company responds officially as follows: 
   First, this company product composition method and the packing design, do not have any Tsh Biopharm Co., Ltd. called the violation patent and violates the fair method circumstances. 
   Second, this dispute enters the judicial process, this company plenary powers committee by WISPRO LAW OFFICES OF INTERNATIONAL COMMERCE agent. 
8.Countermeasures:Publish material information 
9.Any other matters that need to be specified:None